SARS-CoV-2 Fusion Domain Provides Clues toward the Molecular Mechanism for Membrane Fusion
SARS-CoV-2 Fusion Domain Provides Clues toward the Molecular Mechanism for Membrane Fusion
复制标题
SARS-CoV-2融合域为膜融合的分子机制提供线索
DOI:
10.1021/acs.biochem.3c00501
复制
发表时间:
2023
期刊:
影响因子:
2.9
通讯作者:
Lee, Jinwoo
中科院分区:
文献类型:
--
作者:
Birtles, Daniel;Lee, Jinwoo
The viral lifecycle is a highly optimized series of intricate processes that allows a virus to take advantage of a host cell’s own molecular machinery to produce additional viral particles. Every step of the lifecycle is integral to the virus, and thus, in order to understand how to better protect ourselves against viral infections, we must first understand how these viruses can effectively survive on a molecular level. Entry into a target cell is a critical component of the viral lifecycle, which in the coronavirus family is facilitated by the spike glycoprotein (Figure 1). This process can be split into receptor binding and membrane fusion, which are carried out by the two functional subunits of the spike glycoprotein, S1 and S2, respectively. The receptor binding domain (RBD) found in S1 interacts with the target cell receptor, angiotensinconverting enzyme 2 (ACE2). Once bound, a cleavage event then occurs at the S2′ cleavage site, which releases the fusion domain (FD) at the N-terminus of the cleaved S2 subunit (S2′). The FD is then free to interact with the target cell membrane, which initiates a cascade of structural rearrangements in S2′ that ultimately results in membrane fusion and delivery of the viral genome into the host cell. Following the initial outbreak of SARS-CoV-1 in 2002, a significant increase in research surrounding the coronavirus family took place to identify the FD. Several membraneinteracting regions were quickly identified, characterized, and proposed, with most evidence pointing toward the N-terminus of S2′ as the most likely candidate. Over the next 10 years, Lai and co-workers discovered that this FD consisted of two functional units that could interact with and perturb lipid membranes both when independently synthesized and in synergy to even greater effect. 1 While this research was carried out in SARS-CoV-1, strong sequence conservation suggested that this was applicable to all members of the coronavirus family. This led to the coronavirus FD being labeled as a bipartite system that forms an extended fusion platform because of it containing two regions that can elicit fusion. Further investigation into the SARS-CoV-2 FD led to the discovery of two structurally independent regions within the domain itself. At the N-terminus of S2′ exists the fusion peptide (FP; S816-G838), which comprises the first 23 amino acids of the FD in a helix-turn-helix motif. This structural motif allows the FP to bury within the membrane, with the turn being the deepest point of insertion. Immediately following the FP is the fusion loop (FL; D839-F855), formed by a conserved disulfide bond. The FL contains no discernible secondary structure and only superficially interacts with the membrane. It is our belief that the nomenclature FP and FL most clearly describes the two regions because it reinforces the fact that they are two distinct structures within a single domain that retain key similarities to previously described and wellestablished fusogenic regions found in other viruses. Around the same time, the structure of the FD in a lipid bilayer was published and verified these structural findings. 2 Further work was then undertaken to understand the molecular details of how the FD initiates fusion, through the individual perturbation of the FP and FL. A significant decrease in fusogenic ability was witnessed for the FD when a key hydrophobic motif within the FP,“LLF,” was disrupted via mutagenesis and also when the disulfide bond within the FL was severed. 3 Those results indicated a complex, synergistic mechanism that involves both the FP and FL to such a capacity where neither region can efficiently initiate fusion without the other fully intact.Atomic resolution structures of the full …